+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2020

  • ID: 4986893
  • Drug Pipelines
  • January 2020
  • Region: Global
  • 99 pages
  • Global Markets Direct
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Acacia Pharma Ltd
  • Aphios Corp
  • Axim Biotechnologies Inc
  • Ci Therapeutics
  • Huons Co Ltd
  • MannKind Corp
  • MORE
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2020

Summary

The latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2020, provides an overview of the Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline landscape.

Chemotherapy induced nausea and vomiting or CINV is nausea and vomiting that results specifically from treatment with chemotherapy drugs. Symptoms include a rapid heart rate, sweating, dizziness and increased saliva. Risk factors include age, drug, dose, schedule of administration and route.

Report Highlights

The Pharmaceutical and Healthcare latest pipeline guide Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Chemotherapy Induced Nausea and Vomiting (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 2, 3, 8, 1, 11, 3 and 3 respectively.

Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Chemotherapy Induced Nausea and Vomiting (Toxicology).
  • The pipeline guide reviews pipeline therapeutics for Chemotherapy Induced Nausea and Vomiting (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Chemotherapy Induced Nausea and Vomiting (Toxicology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Chemotherapy Induced Nausea and Vomiting (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Chemotherapy Induced Nausea and Vomiting (Toxicology)
Reasons to buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Chemotherapy Induced Nausea and Vomiting (Toxicology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Acacia Pharma Ltd
  • Aphios Corp
  • Axim Biotechnologies Inc
  • Ci Therapeutics
  • Huons Co Ltd
  • MannKind Corp
  • MORE
  • Introduction
  • Chemotherapy Induced Nausea and Vomiting - Overview
  • Chemotherapy Induced Nausea and Vomiting - Therapeutics Development
  • Chemotherapy Induced Nausea and Vomiting - Therapeutics Assessment
  • Chemotherapy Induced Nausea and Vomiting - Companies Involved in Therapeutics Development
  • Chemotherapy Induced Nausea and Vomiting - Drug Profiles
  • Chemotherapy Induced Nausea and Vomiting - Dormant Projects
  • Chemotherapy Induced Nausea and Vomiting - Discontinued Products
  • Chemotherapy Induced Nausea and Vomiting - Product Development Milestones
  • Appendix
List of Tables
  • Number of Products under Development for Chemotherapy Induced Nausea and Vomiting, H1 2020
  • Number of Products under Development by Companies, H1 2020
  • Products under Development by Companies, H1 2020
  • Products under Development by Companies, H1 2020 (Contd..1), H1 2020
  • Number of Products by Stage and Target, H1 2020
  • Number of Products by Stage and Mechanism of Action, H1 2020
  • Number of Products by Stage and Route of Administration, H1 2020
  • Number of Products by Stage and Molecule Type, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Acacia Pharma Ltd, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by AcuCort AB, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Amzell BV, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Aphios Corp, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Artelo Biosciences Inc, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Athenex Inc, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Axim Biotechnologies Inc, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Bod Australia Ltd, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Camurus AB, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Ci Therapeutics, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Daewoong Pharmaceutical Co Ltd, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Emerald Bioscience Inc, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Ethicann Pharmaceuticals Inc, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Helsinn Group, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Hoverink Biotechnologies Inc, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Huons Co Ltd, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by IntelGenx Corp, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by LipoSeuticals Inc, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Luxena Pharmaceuticals Inc, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by MannKind Corp, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Maxinase Life Sciences Ltd, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Nevakar Inc, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Pivot Pharmaceuticals Inc, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Serina Therapeutics Inc, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by SoluBest Ltd, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Starton Therapeutics Inc, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Pipeline by Suda Pharmaceuticals Ltd, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Dormant Projects, H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Dormant Projects, H1 2020 (Contd..1), H1 2020
  • Chemotherapy Induced Nausea and Vomiting - Discontinued Products, H1 2020
List of Figures
  • Number of Products under Development for Chemotherapy Induced Nausea and Vomiting, H1 2020
  • Number of Products under Development by Companies, H1 2020
  • Number of Products by Targets, H1 2020
  • Number of Products by Stage and Targets, H1 2020
  • Number of Products by Mechanism of Actions, H1 2020
  • Number of Products by Stage and Mechanism of Actions, H1 2020
  • Number of Products by Routes of Administration, H1 2020
  • Number of Products by Stage and Routes of Administration, H1 2020
  • Number of Products by Stage and Top 10 Molecule Types, H1 2020
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Acacia Pharma Ltd
  • AcuCort AB
  • Amzell BV
  • Aphios Corp
  • Artelo Biosciences Inc
  • Athenex Inc
  • Axim Biotechnologies Inc
  • Bod Australia Ltd
  • Camurus AB
  • Ci Therapeutics
  • Daewoong Pharmaceutical Co Ltd
  • Emerald Bioscience Inc
  • Ethicann Pharmaceuticals Inc
  • Helsinn Group
  • Hoverink Biotechnologies Inc
  • Huons Co Ltd
  • IntelGenx Corp
  • LipoSeuticals Inc
  • Luxena Pharmaceuticals Inc
  • MannKind Corp
  • Maxinase Life Sciences Ltd
  • Nevakar Inc
  • Pivot Pharmaceuticals Inc
  • Serina Therapeutics Inc
  • SoluBest Ltd
  • Starton Therapeutics Inc
  • Suda Pharmaceuticals Ltd
Note: Product cover images may vary from those shown
Adroll
adroll